T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLD
851
DELISTED
TopBuild
BLD
| $42.8M | ﹤0.01% |
102,561
+1,546
| +2% | +$663K |
|
852
Rubrik
RBRK
$21.6B
| $42.6M | ﹤0.01% |
556,359
-642,531
| -54% | -$49.3M |
|
853
Tarsus Pharmaceuticals
TARS
$3.02B
| $42.5M | ﹤0.01% |
518,780
+65,923
| +15% | +$4.92M |
|
854
DraftKings
DKNG
$12.6B
| $42.3M | ﹤0.01% |
1,228,426
-511,879
| -29% | -$16.8M |
|
855
F5
FFIV
$23.6B
| $42.2M | ﹤0.01% |
165,134
+42,509
| +35% | +$11.4M |
|
856
Brown & Brown
BRO
$24B
| $42.1M | ﹤0.01% |
527,749
-150,328
| -22% | -$12.5M |
|
857
Universal Technical Institute
UTI
$1.42B
| $41.8M | ﹤0.01% |
1,599,534
+631,070
| +65% | +$17.9M |
|
858
General Mills
GIS
$20.8B
| $41.7M | ﹤0.01% |
896,599
+10,151
| +1% | +$482K |
|
859
Archer Daniels Midland
ADM
$38.6B
| $41.6M | ﹤0.01% |
724,007
+3,366
| +0.5% | +$201K |
|
|
SF
860
Stifel
SF
$12.9B
| $41.5M | ﹤0.01% |
497,594
+74,931
| +18% | +$5.99M |
|
861
Credicorp
BAP
$29.8B
| $41.4M | ﹤0.01% |
144,247
-35,205
| -20% | -$9.32M |
|
862
Trade Desk
TTD
$6.84B
| $41M | ﹤0.01% |
1,081,069
-1,195,858
| -53% | -$53M |
|
|
CBC
863
Central Bancompany Inc
CBC
$7.95B
| $40.8M | ﹤0.01% |
+1,691,102
| New | +$39.8M |
|
864
Axalta
AXTA
$7.93B
| $40.8M | ﹤0.01% |
1,261,928
-665,869
| -35% | -$19.5M |
|
865
Zegna
ZGN
$3.73B
| $40.6M | ﹤0.01% |
3,961,744
-36,385
| -0.9% | -$371K |
|
|
SW
866
Smurfit Westrock
SW
$26.2B
| $40.6M | ﹤0.01% |
1,048,619
+2,828
| +0.3% | +$108K |
|
867
Extra Space Storage
EXR
$31.6B
| $40.5M | ﹤0.01% |
311,153
-1,486
| -0.5% | -$203K |
|
868
Dow Inc
DOW
$21.9B
| $40.5M | ﹤0.01% |
1,731,953
-57,242
| -3% | -$1.32M |
|
869
Visteon
VC
$2.86B
| $40.5M | ﹤0.01% |
425,688
+81,293
| +24% | +$8.61M |
|
870
D-Wave Quantum Inc. Common Stock
QBTS
$7.78B
| $40.4M | ﹤0.01% |
1,543,731
-3,037,038
| -66% | -$88.5M |
|
871
UFP Technologies
UFPT
$2.48B
| $40.3M | ﹤0.01% |
181,483
+1,500
| +0.8% | +$321K |
|
872
McCormick & Company Non-Voting
MKC
$14.6B
| $40.3M | ﹤0.01% |
591,503
-12,447
| -2% | -$827K |
|
|
BLLN
873
BillionToOne Inc
BLLN
$4.44B
| $39.7M | ﹤0.01% |
+485,283
| New | +$49.2M |
|
874
Oscar Health
OSCR
$9.5B
| $39.7M | ﹤0.01% |
2,760,765
-238,853
| -8% | -$4.13M |
|
875
Texas Roadhouse
TXRH
$13.6B
| $39.5M | ﹤0.01% |
238,069
-23,076
| -9% | -$3.9M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.